2339 GMT - Ansell's bull at Macquarie continues to see value in the stock despite the share-price surge that met the protective-garment maker's stronger-than-expected first-half earnings. An analyst note from the investment bank tells clients that the Australia-listed company's upgraded full-year guidance implies 4% in annual organic Ebit growth. The bank's analyst is slightly more optimistic on this metric, and forecasts 5% organic Ebit growth. The stock jumped 8.1% on release of the first-half result, but Macquarie maintains its outperform rating. Its target price rises 26% to A$40.30. Shares are down 2.6% at A$36.79. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
February 10, 2025 18:39 ET (23:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.